Sleep Disorders Trial, Recruiting (NCT06586268)

Sleep Disorders Trial, Recruiting NCT06586268 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06586268 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with obstructive sleep apnea (OSA), whether or not they are currently being treated for it, and who are scheduled for planned (non-emergency) surgery at the AUMC operating theatres with an expected hospital stay of at least 3 nights
People who use a CPAP machine or a mandibular advancement device (a mouthguard-type device worn during sleep) are considered to have treatment for OSA and may be eligible
People aged 18 years or older
People who speak Dutch or English
People who are willing and able to give written consent for their medical care data to be used for research purposes

Who may not be able to join:

People under 18 years of age
People who do not speak Dutch or English
People who do not give consent for their medical care data to be used for research purposes
People whose surgery is scheduled as a same-day procedure, or whose expected discharge from hospital is before the third night after surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jeroen Hermanides, Prof. Dr., AmsterdamUMC

Phone: +31205669111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06586268

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +31205669111

More information: https://clinicaltrials.gov/study/NCT06586268

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with obstructive sleep apnea (OSA), whether or not they are currently being treated for it, and who are scheduled for planned (non-emergency) surgery at the AUMC operating theatres with an expected hospital stay of at least 3 nights
People who use a CPAP machine or a mandibular advancement device (a mouthguard-type device worn during sleep) are considered to have treatment for OSA and may be eligible
People aged 18 years or older
People who speak Dutch or English
People who are willing and able to give written consent for their medical care data to be used for research purposes

Who may not be able to join:

People under 18 years of age
People who do not speak Dutch or English
People who do not give consent for their medical care data to be used for research purposes
People whose surgery is scheduled as a same-day procedure, or whose expected discharge from hospital is before the third night after surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Registry

ClinicalTrials.gov

Start date

1 October 2024

Est. completion

1 July 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

AHI and Desaturations on night one and three after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov